Large-scale testing (Phase 3)WithdrawnNCT04129320
What this trial is testing
Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and Neck
Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of Head and Neck
MacroGenics